Targeting CD38 in Subclinical Antibody-mediated Rejection in HLA-incompatible Kidney Transplantation: A Case Report

• Ondrej Viklicky, MD, PhD,
• Petra Hruba, PhD,
• Marek Novotny, MD,
• Martin Kment, MD,
• Matej Roder, PhD,
• Philip F. Halloran, MD, PhD,
• Georg A. Böhmig, MD

Affiliations

Ondrej Viklicky, MD, PhD

1 Department of Nephrology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.

Petra Hruba, PhD

2 Transplant Laboratory, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.

Marek Novotny, MD

1 Department of Nephrology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.

Martin Kment, MD

3 Department of Pathology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.

Matej Roder, PhD

4 Department of Immunogenetics, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.

Philip F. Halloran, MD, PhD

5 Alberta Transplant Applied Genomics Centre, Edmonton, AB, Canada.

Georg A. Böhmig, MD

6 Division of Nephrology and Dialysis, Department of Medicine III, Medical University Vienna, Vienna, Austria.